Eucure Biopharma

About:

Eucure Biopharma is a biotechnology company that develops immuno-oncology targeted antibodies.

Website: http://www.eucure.com/en

Top Investors: SDIC Venture Capital, CMB International Capital Corporation, BVCF, 3E Bioventures

Description:

Eucure Biopharma is a global biotechnology company headquartered in Beijing, China. They are committed to the discovery and development of innovative immuno-oncology targeted antibodies which mainly focus on immune checkpoints. Several products have entered the CMC stage and has applied for clinical trial in 2019. Their mission is to develop antibody treatments to improve the survival rate of tumor patients.

Total Funding Amount:

250M CNY

Headquarters Location:

Beijing, Beijing, China

Founded Date:

2016-11-01

Contact Email:

info(AT)eucure.com

Founders:

Jian Ni, Yuelei Shen

Number of Employees:

11-50

Last Funding Date:

2018-03-28

IPO Status:

Private

Industries:

© 2025 bioDAO.ai